KETAMINE HYDROCHLORIDE INJECTION USP 100 MG / 2 ML
KETAMINE (KETAMINE HYDROCHLORIDE) : 100 MG / 2 ML · DIN 02470934 · STERIMAX INC
Health Canada status: APPROVED
What is KETAMINE HYDROCHLORIDE INJECTION USP?
KETAMINE HYDROCHLORIDE INJECTION USP 100 MG / 2 ML contains KETAMINE (KETAMINE HYDROCHLORIDE) : 100 MG / 2 ML. It is listed in the Health Canada Drug Product Database under DIN 02470934, held by STERIMAX INC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as approved, status dated 21-Dec-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02470934 |
|---|---|
| Brand name | KETAMINE HYDROCHLORIDE INJECTION USP |
| Generic / active ingredient | KETAMINE (KETAMINE HYDROCHLORIDE) : 100 MG / 2 ML |
| Manufacturer | STERIMAX INC |
| Strength | 100 MG / 2 ML |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N01AX03 KETAMINE |
| AHFS class | 28:04.08 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 21-Dec-2017 |
Is KETAMINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by SANDOZ CANADA INCORPORATED, last seen 05 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N01AX03 KETAMINE. 7 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| KETALAR | 10 MG | SOLUTION | SEARCHLIGHT PHARMA INC | MARKETED | DIN 00224391 |
| KETALAR | 50 MG | SOLUTION | SEARCHLIGHT PHARMA INC | MARKETED | DIN 00224405 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02246795 |
| KETAMINE HYDROCHLORIDE INJECTION USP | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02246796 |
| KETAMINE HYDROCHLORIDE INJECTION, USP | 10 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02550431 |
| KETAMINE HYDROCHLORIDE INJECTION, USP | 50 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02550458 |
| KETAMINE INJECTION, BP | 50 MG | SOLUTION | STERIMAX INC | MARKETED | DIN 02535645 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02387301 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02387336 |
| KETAMINE HYDROCHLORIDE INJECTION SDZ | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02387328 |
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ask about availability of KETAMINE HYDROCHLORIDE INJECTION USP
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.